Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Harmonization, regulation, and trade: where do we go from here?

PDA Journal of Pharmaceutical Science and Technology

|January 1, 1996

Summary

The U.S. Food and Drug Administration (FDA) is enhancing global collaboration in pharmaceutical regulations. This involves international harmonization initiatives, including the International Council for Harmonisation (ICH), to streamline drug approvals worldwide.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Contributions of Kv7-mediated potassium current to sub- and suprathreshold responses of rat layer II/III neocortical pyramidal neurons.

Journal of neurophysiology·2011

Same author

Food from developing countries: steps to improve compliance.

Food and drug law journal·2002

Same author

Risk analysis and the law: international law, the World Trade Organization, Codex Alimentarius and national legislation.

Food additives and contaminants·2002

Same author

A plan that establishes a framework for achieving mutual recognition of good manufacturing practices inspections.

Food and drug law journal·1999

Same author

International update.

PDA journal of pharmaceutical science and technology·1995

Same author

Medical device regulation in the European Union.

Food and drug law journal·1995

Area of Science:

Regulatory Science
Pharmaceutical Policy
Global Health Standards

Background:

The U.S. Food and Drug Administration (FDA) is increasing its engagement in international regulatory harmonization.
Key drivers include global trade, multinational pharmaceutical operations, trade agreements (NAFTA, WTO), and European regulatory initiatives.
Cost containment pressures within the healthcare industry, such as intense competition and reimbursement controls, also influence this direction.

Discussion:

The International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) is central to the FDA's pharmaceutical harmonization efforts.
The FDA collaborates with international bodies like the World Health Organization (WHO) to establish global healthcare product standards.
These collaborative efforts aim to create more efficient and consistent regulatory pathways for pharmaceuticals.

Key Insights:

Increased global trade and the international nature of the pharmaceutical industry necessitate harmonized regulatory approaches.
Trade agreements and international cooperation are pivotal in shaping the FDA's global regulatory strategy.
The ICH serves as a primary platform for the FDA to harmonize technical requirements for drug registration.

Outlook:

Continued expansion of international harmonization activities by the FDA is anticipated.
Further collaboration with global regulatory agencies and international organizations will be crucial.
Harmonization efforts are expected to facilitate faster access to safe and effective medicines globally.

Related Experiment Videos